Lafayette Investments’s GSK GSK Stock Holding History

Lafayette Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21M	Hold	23,060	–	–	0.22%	75
2026 Q1	$1.27M	Sell	23,060 -240	-1%	-$13K	0.26%	63
2025 Q4	$1.14M	Hold	23,300	–	–	0.22%	72
2025 Q3	$1.01M	Hold	23,300	–	–	0.19%	69
2025 Q2	$895K	Hold	23,300	–	–	0.18%	71
2025 Q1	$903K	Hold	23,300	–	–	0.19%	66
2024 Q4	$788K	Hold	23,300	–	–	0.17%	72
2024 Q3	$953K	Hold	23,300	–	–	0.2%	65
2024 Q2	$897K	Sell	23,300 -1,300	-5%	-$54.7K	0.2%	68
2024 Q1	$1.05M	Hold	24,600	–	–	0.24%	63
2023 Q4	$912K	Sell	24,600 -80	-0.3%	-$2.87K	0.23%	66
2023 Q3	$895K	Sell	24,680 -420	-2%	-$14.9K	0.24%	64
2023 Q2	$895K	Hold	25,100	–	–	0.24%	66
2023 Q1	$893K	Buy	25,100 +1,817	+8%	+$63.6K	0.25%	67
2022 Q4	$818K	Hold	23,283	–	–	0.23%	69
2022 Q3	$685K	Hold	23,283	–	–	0.21%	68
2022 Q2	$1.27M	Hold	23,283	–	–	0.37%	58
2022 Q1	$1.27M	Hold	23,283	–	–	0.31%	61
2021 Q4	$1.28M	Hold	23,283	–	–	0.32%	62
2021 Q3	$1.11M	Hold	23,283	–	–	0.3%	63
2021 Q2	$1.16M	Buy	23,283 +683	+3%	+$32.8K	0.32%	63
2021 Q1	$1.01M	Hold	22,600	–	–	0.32%	57
2020 Q4	$1.04M	Hold	22,600	–	–	0.35%	57
2020 Q3	$1.06M	Sell	22,600 -320	-1%	-$16K	0.41%	54
2020 Q2	$1.17M	Hold	22,920	–	–	0.49%	50
2020 Q1	$1.09M	Hold	22,920	–	–	0.52%	45
2019 Q4	$1.35M	Hold	22,920	–	–	0.47%	47
2019 Q3	$1.22M	Hold	22,920	–	–	0.44%	46
2019 Q2	$1.15M	Hold	22,920	–	–	0.41%	45
2019 Q1	$1.2M	Hold	22,920	–	–	0.44%	45
2018 Q4	$1.09M	Sell	22,920 -1,142	-5%	-$56.2K	0.44%	45
2018 Q3	$1.21M	Buy	24,062 +1,010	+4%	+$51.3K	0.42%	42
2018 Q2	$1.16M	Hold	23,052	–	–	0.43%	43
2018 Q1	$1.13M	Sell	23,052 -6,400	-22%	-$298K	0.42%	42
2017 Q4	$1.31M	Hold	29,452	–	–	0.47%	41
2017 Q3	$1.5M	Hold	29,452	–	–	0.56%	39
2017 Q2	$1.59M	Hold	29,452	–	–	0.59%	39
2017 Q1	$1.55M	Hold	29,452	–	–	0.57%	38
2016 Q4	$1.42M	Hold	29,452	–	–	0.54%	37
2016 Q3	$1.59M	Hold	29,452	–	–	0.64%	35
2016 Q2	$1.6M	Hold	29,452	–	–	0.65%	34
2016 Q1	$1.49M	Hold	29,452	–	–	0.62%	34
2015 Q4	$1.49M	Hold	29,452	–	–	0.62%	36
2015 Q3	$1.42M	Hold	29,452	–	–	0.62%	35
2015 Q2	$1.53M	Hold	29,452	–	–	0.64%	34
2015 Q1	$1.7M	Hold	29,452	–	–	0.72%	33
2014 Q4	$1.57M	Hold	29,452	–	–	0.66%	33
2014 Q3	$1.69M	Hold	29,452	–	–	0.76%	32
2014 Q2	$1.97M	Hold	29,452	–	–	0.87%	31
2014 Q1	$1.97M	Hold	29,452	–	–	0.9%	31
2013 Q4	$1.97M	Sell	29,452 -800	-3%	-$51.9K	0.92%	31
2013 Q3	$1.9M	Hold	30,252	–	–	0.92%	32
2013 Q2	$1.89M	Buy	+30,252	New	+$1.92M	0.91%	33

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Lafayette Investments's GSK Position: Q2 2026 in Review

Lafayette Investments held its GSK (GSK) position steady in Q2 2026 at 23,060 shares worth $1.21M. The position accounts for 0.22% of the portfolio, ranked #75.

Lafayette Investments first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.97M in Q2 2014. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Lafayette Investments held 23,060 shares of GSK worth $1.21M as of Q2 2026.
Lafayette Investments left its GSK share count unchanged in Q2 2026.
GSK made up 0.22% of Lafayette Investments's portfolio in Q2 2026, its #75 holding.
Lafayette Investments first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
Lafayette Investments's GSK position peaked at $1.97M in Q2 2014.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Lafayette Investments's 13F filing for Q2 2026, filed 11 Aug 2026.